Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:1331-1337

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Su, E. J.
Right arrow Articles by Schwartz, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Su, E. J.
Right arrow Articles by Schwartz, S. M.

(Hypertension. 1998;31:1331-1337.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Angiotensin II Induces Vascular Smooth Muscle Cell Replication Independent of Blood Pressure

Enming J. Su; Donna M. Lombardi; Justin Siegal; ; Stephen M. Schwartz

From the Department of Pathology, University of Washington (Seattle).

Correspondence to E.J. Su, Department of Pathology, Box 357335, Seattle WA 98195. E-mail enmingsu{at}u.washington.edu

Abstract—The purpose of this investigation was to evaluate the role of blood pressure in the proliferative response of vascular smooth muscle cells to systemic infusion of angiotensin II (Ang II). Our laboratory has previously shown that infusion of Ang II induces smooth muscle cell proliferation in rat mesenteric vessels and carotid arteries. Ang II, a strong vasopressor, raised systolic blood pressure in rats from 120 to 200 mm Hg at a dose of 435 ng · kg-1 · min-1 after 1 week of treatment. The question arises as to whether this development of hypertension is a primary contributor to the replicative activities observed in the arterial wall of the mesenteric arteries or the carotid arteries or whether Ang II alone, without an increase in blood pressure, is sufficient to stimulate proliferation in these vessels. In the previous studies, we found that Ang II stimulated smooth muscle cell replication in the carotid artery and in type III and type I mesenteric microvessels. This study demonstrates that although administration of hydralazine normalizes the animals' blood pressures, it does not suppress the mitogenic effect of Ang II. Thus, it appears that Ang II has a direct effect on cell proliferation.


Key Words: angiotensin II • hyperplasia • hypertrophy • muscle, smooth • mesenteric arteries • proliferation




This article has been cited by other articles:


Home page
HypertensionHome page
J. Nussberger, J.-F. Aubert, K. Bouzourene, M. Pellegrin, D. Hayoz, and L. Mazzolai
Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression: Comparison With Irbesartan, Atenolol, and Amlodipine
Hypertension, May 1, 2008; 51(5): 1306 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. F. Navedo, G. C. Amberg, R. E. Westenbroek, M. J. Sinnegger-Brauns, W. A. Catterall, J. Striessnig, and L. F. Santana
Cav1.3 channels produce persistent calcium sparklets, but Cav1.2 channels are responsible for sparklets in mouse arterial smooth muscle
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1359 - H1370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. H. P. Hilgers and R. C. Webb
Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2275 - H2284.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. C. Amberg, M. F. Navedo, M. Nieves-Cintron, J. D. Molkentin, and L. F. Santana
Calcium sparklets regulate local and global calcium in murine arterial smooth muscle
J. Physiol., February 15, 2007; 579(1): 187 - 201.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P W F Hadoke, R S Lindsay, J R Seckl, B R Walker, and C J Kenyon
Altered vascular contractility in adult female rats with hypertension programmed by prenatal glucocorticoid exposure.
J. Endocrinol., March 1, 2006; 188(3): 435 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Mazzolai, M. A. Duchosal, M. Korber, K. Bouzourene, J. F. Aubert, H. Hao, V. Vallet, H. R. Brunner, J. Nussberger, G. Gabbiani, et al.
Endogenous Angiotensin II Induces Atherosclerotic Plaque Vulnerability and Elicits a Th1 Response in ApoE-/- Mice
Hypertension, September 1, 2004; 44(3): 277 - 282.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. A. Tallant and M. A. Clark
Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Hypertension, October 1, 2003; 42(4): 574 - 579.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. E.G. Eskildsen-Helmond and M. J. Mulvany
Pressure-Induced Activation of Extracellular Signal-Regulated Kinase 1/2 in Small Arteries
Hypertension, April 1, 2003; 41(4): 891 - 897.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Virdis, M. F. Neves, F. Amiri, E. Viel, R. M. Touyz, and E. L. Schiffrin
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Hypertension, October 1, 2002; 40(4): 504 - 510.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
M. W Manning, L. A Cassis, J. Huang, S. J Szilvassy, and A. Daugherty
Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease
Vascular Medicine, February 1, 2002; 7(1): 45 - 54.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Moreno, A. Lopez, M. T. Llinas, F. Rodriguez, A. Lopez-Farre, E. Nava, and F. J. Salazar
Changes in NOS activity and protein expression during acute and prolonged ANG II administration
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R31 - R37.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Ibrahim, A. D. Hughes, and P. S. Sever
Action of Angiotensin II on DNA Synthesis by Human Saphenous Vein in Organ Culture
Hypertension, November 1, 2000; 36(5): 917 - 921.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Matrougui, Y. E. G. Eskildsen-Helmond, A. Fiebeler, D. Henrion, B. I. Levy, A. Tedgui, and M. J. Mulvany
Angiotensin II Stimulates Extracellular Signal-Regulated Kinase Activity in Intact Pressurized Rat Mesenteric Resistance Arteries
Hypertension, October 1, 2000; 36(4): 617 - 621.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ueno, P. Kanellakis, A. Agrotis, and A. Bobik
Blood Flow Regulates the Development of Vascular Hypertrophy, Smooth Muscle Cell Proliferation, and Endothelial Cell Nitric Oxide Synthase in Hypertension
Hypertension, July 1, 2000; 36(1): 89 - 96.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Mervaala, D. N. Muller, F. Schmidt, J.-K. Park, V. Gross, M. Bader, V. Breu, D. Ganten, H. Haller, and F. C. Luft
Blood Pressure-Independent Effects in Rats With Human Renin and Angiotensinogen Genes
Hypertension, February 1, 2000; 35(2): 587 - 594.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. A. Tallant, D. I. Diz, and C. M. Ferrario
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
Hypertension, October 1, 1999; 34(4): 950 - 957.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. B. Strawn, C. M. Ferrario, and E. A. Tallant
Angiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Hypertension, January 1, 1999; 33(1): 207 - 211.
[Abstract] [Full Text] [PDF]